ArticleAdvances in therapy2018

Evaluating the Impact and Benefits of Fluticasone Furoate/Vilanterol in Individuals with Asthma or COPD: A Mixed-Methods Analysis of Patient Experiences.

Henrik Svedsater et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.